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SUMMARY
Objective. To investigate cleft disordered tissue in children with cleft palate and cleft lip 
with or without alveolar clefting for detection of local tissue growth factors and growth factor 
receptors and compare fi ndings.
Design. Morphological analysis of human tissue.
Patients. Three groups were studied: 14 patients with cleft palate at the age from eight months 
to 18 years and two months, 12 patients with cleft lip with or without alveolar clefting in the age 
from four months to 15 years and four months and 11 control patients.
Results. In general, cleft palate disordered tissue showed more prominent expression of 
BMP2/4 (z=3.574; p=0.0004) and TGFβ (z=2.127; p=0.033), while expression of TGFBR3 
signifi cantly higher was only in connective tissue (z=3.822; p=0.0001). Cleft lip affected tis-
sue showed signifi cantly pronounced expression of FGFR1 in general as well as separately in 
epithelium.
Conclusions. The marked and statistically signifi cant expression of BMP 2/4 in cleft palate 
disordered soft tissue probably is delayed, but still proliferation and differentiation as well as 
tissue, especially, bone remodeling contributing signal. Cleft palate affected tissue show more 
prominent expression of TGFβ, still the weak regional expression of TGFβ type III receptors prove 
the disordered tissue growth and changed TGFβ signalling pathway in postnatal pathogenesis. In 
general, expression of TGFβ, BMP 2/4 and FGFR1 is signifi cantly different, giving evidence to 
the involvement of these mentioned factors in the cleft severity morphopathogenesis.
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INTRODUCTION
Clefts of the lip and palate are among the most 
common birth defects worldwide. In Latvia the cleft 
lip and cleft palate occur on the average in one child 
in 700-800 newborn infants, which is the second 
widely met pathology in embryos and fetus (1, 2). 
Development of the face and jaws is the product 
of growth and fusion of fi ve facial prominences and 
involves cell migration, proliferation, differentiation 
and apoptosis. These primordiae consist of a mesen-
chymal core derived mainly from the cranial neural 
crest cells and of an ectodermally derived epithelial 
outer covering (3). One of more complicated event 
is development of secondary palate. The main part 
of secondary palate is formed by two shelf-like 
outgrowths from the maxillary prominences. Men-
tioned palatal primordiae are covered by medial edge 
epithelium (MEE). After fusion of palatal shelves 
MEE adhere forming epithelial midline edge seam 
(MES), what is one of the more investigated mo-
ments in the development of secondary palate (4). 
Moreover, the exact fate of the epithelia in the MES 
is still controversial, and three major pathways have 
been proposed for their disappearance: apoptosis, 
migration to the oral or nasal side of the palate, 
and epithelial-mesenchymal transformation (5-7). 
That is also still emphasided in the review article of 
Iseki (8). All mentioned processes in the embryonic 
tissues are caused and regulated by various factors, 
especially some growth factors and growth factor 
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receptors, whose study has been intensifi ed within 
the recent two ten years and is still actively going on.
The most studied secreted proteins in palatal 
development belong to the TGFβ superfamily. 
This is a group of structurally related growth and 
differentiation factors, including TGFβs and bone 
morphogenetic proteins (BMP). Mentioned growth 
factors are involved in many biological processes 
that also occur during palatogenesis, such as cell 
proliferation, apoptosis, extracellular matrix syn-
thesis and deposition, cell migration, epithelial-
mesenchymal transformation, and degradation of 
basement membrane (7, 9).
TGFβ plays important role during various stages 
of palate development (9). It is an extracellular 
protein predominantly produced by a subset of T 
cells and is ubiquitously expressed by all cells. In 
mammals, three isoforms of TGFβ are currently 
identifi ed. All three (TGFβ-1, TGFβ-2, TGFβ-3) of 
these proteins share extensive regions of similarity 
in their amino acids (10). The role of various TGFβ 
isoforms in palate development is still under inves-
tigations. Irrespective of variation of views among 
researchers about the exact timing and localization 
of TGFβ isoforms in palatogenesis, most agree that 
TGFβ-1 plays a crucial role in cell proliferation and 
growth of the shelves. TGFβ-1 and TGF-2 regulate 
mesenchymal cell proliferation and extracellular 
matrix synthesis in the palate, whereas TGFβ-3 
orchestrates fusion of the palatal seam (7, 9). In the 
TGF-β3 null-mutant mice the palatal shelves fail 
to adhere properly, the basement membrane is not 
degraded and the MEE do no disappear from the 
midline seem (11).
TGFβs exert its effect by interacting mainly 
with three membrane proteins named type I (RI), 
type II (RII) and type III (RIII) receptors (12). 
Both type I and type II receptors are transmem-
brane serine/threonine kinases indispensable for 
TGFβ signalling. Type III receptor, also termed 
betaglycan, is a membrane-anchored protein lack-
ing a cytoplasmatic kinase domain, and serves as a 
direct modulator of TGFβ access to the signalling 
receptor. In the presence of activated TGFβ ligands, 
TβR-III forms a transient heteromeric complex with 
TβR-II and presents TGFβ directly to TβR-II (13). 
In co-receptor role TβRIII directly binds ligands 
in the TGFβ superfamily, including BMP-2 and 
BMP-4 (14).
TβR-III has been shown is specifically ex-
pressed in the medial edge epithelium in a distribu-
tion similar to TGFβ3 at critical stages of palatal 
shelf adherence and has a critical role in the palatal 
fusion (11). However, investigations show, that after 
palatal shelves fusion mesenchymal cells continue 
to express TGFβ3, however TβR-III was only ex-
pressed in epithelium (15). Scientists from USA re-
port, that TβRIII is ubiquitously expressed on nearly 
all cell types and is the mostly highly expressed of 
the TGFβ superfamily receptors on those cells, with 
at least 200.000 receptors/cell as opposite to 5000-
10.000 receptors/cell  for most TGFβ superfamily 
type I and type II receptors (14).
The bone morphogenetic proteins (BMPs) as 
mentioned early, belong to the TGFβ superfamily 
and are implicated in the mammalian palate develop-
ment (16). BMP2 and BMP4 are expressed in mam-
malian palate both the epithelia and mesenchyme 
prior to, during and after palatal shelf fusion, but 
mainly act as mesenchymal proliferation contribut-
ing factors (17). Mentioned growth factor signals 
are very important for closure of the upper lip or 
primary palate (18).
The fi broblast growth factors are major regula-
tors in embryonic development. The 22 members 
of the FGF family mediate their cellular responses 
by binding to and activating the different isoforms 
encoded by the four receptor tyrosine kinases 
designated FGFR1, FGFR2, FGFR3 and FGFR4 
(19). These growth factors have emerged as a key 
contributors in epithelial – mesenchymal dialogue 
contributing to morphogenesis of the orofacial 
region and are involved in almost all structures 
development (20). Its known, that basic FGF infl u-
ences collagen synthesis and extracellular matrix 
proteins at the time of mammalian palatal fusion, but 
FGFR1  is expressed specifi cally in the epithelium 
of the developing palatal shelves from the time of 
the outgrowth from the maxillary process through 
completion of fusion (21).
Nonetheless, irrespective of many studies, the 
data on distribution and localization of various 
growth factors and growth factor receptors in human 
cleft-affected tissues are still not clear. Therefore 
in this study we focused on the relative abundance 
and localization of growth factors and growth fac-
tor receptors in children cleft palate and cleft lip-
affected tissue.
The aim of our study was to investigate cleft 
disordered tissue in children with cleft palate and 
cleft lip for detection of local tissue growth factors 
and growth factor receptors, to cross-correlate the 
obtained data. 
MATERIALS AND METHODS
The research is based on the material of cleft lip 
and cleft palate patients, which was gathered within 
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Table 1. Marking of relative frequency of the immunohistochemically deter-
mined structures
a period of time from 2003 to 2006 at the Cleft Lip 
and Palate Centre of the Institute of Stomatology 
of the Riga Stradins University. Permission of the 
Ethics Committee: decision of the RSU Ethics Com-
mittee dated 22nd May 2003.
The research involved 14 patients with cleft 
palate at the age from eight months to 18 years and 
two months and 12 patients with cleft lip with or 
without alveolar clefting in the age from four months 
to 15 years and four months.
The control material was obtained from 11 
patients with oral-facial trauma and cleft-unrelated 
surgical operations. The material was gathered at the 
Institute of Stomatology of the Riga Stradins Uni-
versity within a period of time from 2004 to 2006.
Immunohistochemistry method (Hsu et al., 
1981). Tissues were fi xed for a day in mixture of 
2% formaldehide and 0.2% picric acid in 0.1 M 
phosfate buffer (pH 7.2). After samples were rinsed 
in thyroide buffer, containing 10% sacharose for 12 
hours, then embedded into paraffi n and cut in 6-7 
μm thin sections. Sections were proceeded for detec-
tion of following growth factors and growth factor 
receptors: transforming growth factor beta (TGFβ) 
(code ab 1279, work dilution 1:1000, Abcam, UK), 
transforming growth factor beta receptor type III 
(TGFBRIII) (code LS-B3392, work dilution 1:100, 
LsBio); bone morphogenetic protein 2/4 (BMP 2/4) 
(code AF355, work dilution 1:100, RnDSystems, 
Germany), basic fi broblast growth factor (bFGF) 
(code ab 16828, work dilution 1:200, Abcam, UK), 
fi broblast growth factor receptor 1 (FGFR1) (code 
ab 10646, work dilution 1:100, Abcam, UK).
Routine histological staining with haemotoxylin 
and eosin was developed for each case to get review 
picture of the slide.
Distribution of immunoreactive structures 
was detected semiquantitatively (22, 
23). The quantity of structures was 
analyzed in fi ve visual fi elds of one 
section. Explanatory notes on the ap-
plied markings are given in Table 1. 
Statistical analysis. We used the 
Mann-Whitney test for comparison of 
two independent groups, applying the 
ranking values. Values of p<0.05 were 
considered signifi cant. For compari-
son of a number of samples we used 
the Kruskal Wallis test. 
The correlation coeffi cient r as 
a quantitative indicator of coher-
ence tightness between two or more 
variables calculated for the ranking 
values (Spearman’s Rank Correlation 
Coeffi cient). In the study the qualitative coherence 
tightness between variables, on the grounds of the 
correlation coeffi cient value, was assessed as weak, 
average or tight. The distribution of the correlation 
coefficient was as follows: r=0-0.3, low, insig-
nifi cant correlation; r=0.4-0.7, average correlation; 
r=0.7-0.9, tight correlation. A statistical analysis was 
carried out by means of the SPSS (SPSS Inc., USA).
RESULTS
TGFβ
Control material showed expression of TGFβ 
almost in all cases. Immunoreactive epithelial 
cells were found in the middle layers of stratifi ed 
squamous mucosal epithelium and relative amount 
mainly varied from moderate to numerous, but 
on average was moderate (Table 2).  Underlaying 
connective tissue more frequently contained few 
or rare positive connective tissue cells among them 
infl ammatory cells. Relative amount of TGFβ con-
taining endothelial cells mainly varied from few to 
moderate, but immunoreactivity of vascular smooth 
muscle cells was less pronounced. 
TGFβ immunoreactive epithelial and con-
nective tissue cells we observed in 12 cleft palate 
affected tissue. The relative number of positive 
epitheliocytes was very variable. Mentioned cells 
mainly localized in the middle layers of stratifi ed 
squamous mucosal epithelium and frequently were 
vacuolized. Expression of TGFβ in connective tissue 
was slight and varied from rare to moderate. TGFβ 
positive endothelial cells mainly in the walls of 
sclerotic blood vessels and vascular smooth muscle 
cells we observed in all cleft palate affected tissues. 
In general, expression of TGFβ in cleft lip af-
fected tissue was less pronounced. Mainly we found 




- No positive structure seen in the visual fi eld
0/+ Rare positive structures seen in the visual fi eld
+ Few positive structures seen in the visual fi eld
+/++ Few to moderate number of positive structures seen in the 
visual fi eld
++ Moderate number of positive structures seen in the visual 
fi eld
++/+++ Moderate to numerous positive structures seen in the visual 
fi eld
+++ Numerous positive structures seen in the visual fi eld
+++/++++ Plenty of positive structures in the visual fi eld
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moderate number of positive mucosal epithelial 
cells.  Immunoreactive epidermal cells as well as 
cells in sebaceous glands and hair follicles were 
detected only in rare cases. The relative number of 
TGFβ containing connective tissue cells was very 
variable. Mentioned growth factor also marked vari-
able number of endothelial and smooth muscle cells 
in the walls of blood vessels. Moreover, the relative 
number of positive structures exactly in the walls of 
blood vessels was statistically signifi cantly less than 
in cleft palate disordered tissue (z=2.455; p=0.014).
Moreover, as well as in general Mann-Whitney 
showed statistically signifi cant differences between 
relative number of TGFβ containing structures in 
cleft palate and cleft lip patients groups (z=2.127; 
p=0.033) (Table 3).
TGFBR3
Expression of TGFBR3 in epithelium and in the 
walls of blood vessels we didn’t found in any control 
material. Mentioned receptors mainly marked rare 
or few connective tissue cells among them infl am-
matory cells. 
Expression of TGFBR3 was not characteristic 
for cleft palate disordered epithelium except three 
cases. Relative number of immunoreactive connec-
tive tissue cells varied, but more often it was rare. 
The walls of blood vessels mainly demonstrated 
absence of immunoreactive structures, however, in 
four cases relative number of positive cells consid-
erably varied.
Cleft lip affected tissue showed distinct expres-
sion of TGFBR3 in distribution of positive struc-
tures. We saw positive reaction in basal epithelial 
cells, in basal cells of hair follicle and serous cells of 
minor salivary gland. The immunoreactivity in con-
nective tissue was not found in any case, and this dif-
ference was statistically signifi cant, if compare with 
results with cleft palate affected tissue (z=3.822; 
p=0.0001). Similar as in cleft palate affected tissue, 
we found positive structures in the walls of blood 
vessels in four cases, but expression was slight. 
The relative number of positive structures statisti-
cally signifi cantly differed in epithelium (z=2.804; 
p=0.005), connective tissue (z=4.029; p=0.0001) 
and in the walls of blood vessels (z=1.965; p=0.049), 
TGFß TGFBRIII BMP2/4 bFGF FGFR1






















0/+ ↑ -* 0-+ ++* 0-++* 0-++ 0-0/ 
+-++
-* - ++/ 
+++*
+-++ ++
"-" – no positive structure seen in the visual fi eld, "0/+" – rare positive structures seen in the visual fi eld, "+" – few positive 
structures seen in the visual fi eld, "+/++" – few to moderate number of positive structures seen in the visual fi eld, "++" – 
moderate number of positive structures seen in the visual fi eld, "++/+++" – moderate to numerous positive structures seen 
in the visual fi eld, "+++" – numerous positive structures seen in the visual fi eld, "e." – epithelium, "c.t." – connective tissue, 
"b.v." – blood vessels.
* statistically signifi cant differences  between cleft palate and cleft lip with or without alveolar clefting patients.
TGFß TGFBRIII BMP2/4 bFGF FGFR1





















0/+*  -* 0-+* ++ 0-++* 0-++ 0-0/ 
+-++
-* - ++/ 
+++
+-++ ++
K ++ + +/++ -* 0/+* -* ++ ++* +-++ - 0/+* - ++ 0/+-+ +
"-" – no positive structure seen in the visual fi eld, "0/+" – rare positive structures seen in the visual fi eld, "+" – few positive 
structures seen in the visual fi eld, "+/++" – few to moderate number of positive structures seen in the visual fi eld, "++" – 
moderate number of positive structures seen in the visual fi eld, "++/+++" – moderate to numerous positive structures seen 
in the visual fi eld, "+++" – numerous positive structures seen in the visual fi eld, "e." – epithelium, "c.t." – connective tissue, 
"b.v." – blood vessels.
* statistically signifi cant diferences between cleft palate or cleft lip with or without alveolar clefting patients and control group.
Table 3. Semiquantitative distribution of immunoreactive structures in the material of children with cleft palate (1) and in 
the material of children with cleft lip with or without alveolar clefting (2)
Table 2. Semiquantitative distribution of immunoreactive structures in the material of children with cleft palate (1), in the 
material of children with cleft lip with or without alveolar clefting (2) and in control group patients (K)
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if compared to the control group’s material. More-
over, Spearman’s rank correlation showed weak 
signifi cant correlation between TGFβ and TGFBRIII 
(p=0.045; r=0.205)
BMP 2/4
Expression of BMP 2/4 in control material was 
variable. The relative number of immunoreactive 
epithelial cells mostly varied from few (three cases) 
to moderate (fi ve cases). Findings in connective 
tissue and in the walls of blood vessels also were 
similar and relative amount of positive cells mainly 
varied from few to moderate. 
Cleft palate affected epithelium and connec-
tive tissue showed expression of BMP 2/4 in all 
cases. Relative amount of positive cells in both 
tissues mainly varied from moderate to many. BMP 
2/4 marked variable number endotheliocytes and 
vascular smooth muscle cells in the nine tissue 
samples. Although expression of mentioned growth 
factor in epithelium and connective tissue was more 
pronounced, if compared with control, statistically 
signifi cant differences were not stated. 
Expression of BMP 2/4 in cleft lip disordered 
epithelium was variable. Mainly we found moderate 
immunoreactive cells as well as frequently BMP 2/4 
expressed also cells of hair follicles and sebaceous 
glands. Moreover, we stated, that the difference 
between relative number of positive cells in cleft lip 
and in cleft palate affected epithelium is statistically 
signifi cant (z=2.149; p=0.031). BMP 2/4 marked 
mainly moderate number of connective tissue cells 
in fi ve tissue samples and also moderate number 
of endothelial and vascular smooth muscle cells 
in four cases. Exactly in connective tissue relative 
amount of positive structures was statistically sig-
nifi cantly less, if compared with control (z=2.228; 
p=0.002) and with cleft palate tissue group (z=3.487; 
p=0.0005). Moreover, as well as in general Mann-
Whitney showed statistically signifi cant differences 
between relative number of BMP 2/4-containing 
structures in cleft palate and cleft lip patients groups 
(z=3.574; p=0.0004).
bFGF 
Expression of bFGF in control material was 
slight and rare. 
Expression of bFGF in cleft palate affected 
tissue generally was similar. We saw weak positive 
reaction in epithelium only in four cases. Slight ex-
pression of mentioned growth factor in connective 
tissue cells was found in nine tissue material. Basic 
FGF containing endothelial and vascular smooth 
muscle cells we found in three tissue samples.
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Basic FGF stained variable number of cells of 
sebaceous glands in fi ve cleft lip disordered tissue 
samples. Slight expression in connective tissue and 
vascular smooth muscle cells we found in rare cases. 
Mann-Whitney test demonstrated, that differences 
in relative abundance of positive connective tissue 
cells were statistically signifi cant in comparing with 
control group (z=2.225; p=0.026) and also with cleft 
palate group (z=2.221; p=0.026).
FGFR1
Expression of FGFR1 in the control material 
was found almost in all tissue samples and more 
prominent and regional it was exactly in epithelium. 
FGFR1 mainly stained rare or few number of con-
nective tissue cells as well as cells in the walls of 
blood vessels.
Cleft palate disordered tissue showed variable 
expression of FGFR1 in epithelium, connective tis-
sue and in the walls of blood vessels. It was more 
prominent again in the epithelium. 
Cleft lip affected tissue showed more promi-
nent expression of FGFR1. Moreover, the relative 
number of FGFR1-containing epithelial cells was 
statistically signifi cantly higher than in the patients 
with cleft palate (z=2.875; p=0.004). We found 
immunoreactive mucosal epithelial cells, cells of 
hair follicle, sweat and sebaceous glands. Relative 
amount of FGFR1 containing connective tissue 
cells was variable, but in the walls of blood vessels 
mainly was seen moderate number of immunoreac-
tive structures. In general we observed statistically 
signifi cant differences when compared the relative 
number of immunoreactive structures in cleft lip 
and cleft palate affected tissue (z=2.853; p=0.0043). 
Besides, we found plausibly weak correlation with 
bFGF (p=0.021; r=0.236).
DISCUSSION
TGFβ has regulatory effects on broad spectrum 
of cell types. It regulates cell replication and differ-
entiation, angiogenesis and cellular migration (10). 
All of these processes are important not only in oral 
development, but also in wound healing. Palatal 
connective tissue is dense and basicly is composed 
of bundles of collagen fi bers. TGFβ stimulates the 
synthesis of collagens (10). Thereby we can explain 
pronounced expression of mentioned growth factor 
exactly in cleft palate affected tissue. However, the 
dark side of the TGFβ effects is deposition of extra-
cellular matrix in the sites of injury, what can lead 
to scarring and fi brosis (24). In general cleft palate 
affected tissue show more pronounced expression of 
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TGFβ than  cleft lip disordered tissue and this differ-
ence is statistically signifi cant (z=2.127; p=0.033). 
We can suppose that it depends from heaviness of 
malformation and such moderate expression of 
TGFβ in cleft palate tissue is evaluated as good tis-
sue remodelling fact.
The type III receptor (TGFBR3 or betaglycan) 
was originally characterized as a coreceptor for 
TGFBR2. While TGFBR3 does not have functional 
kinase domain, it binds all three TGFβ isoforms 
and regulates their ability to interact and signal 
through other TGFβ superfamily signalling recep-
tors (25). Immunohistochemical investigations of 
developing mouse palate in vivo and in vitro show 
that the expression of TGFBR3 was not identifi ed 
in the palate during initial morphogenesis, but dra-
matically increased at the time of midline epithelial 
seam formation. So the expression of TGFBR3 was 
temporo-spatially restricted to a subgroup of palatal 
epithelial cells and correlated with the process of 
MEE epithelial-mesenchymal transformation (13). 
Expression of TGFBR3 in epithelium we didn’t 
found in any control material, while in cleft palate 
disordered tissue it was seen in three cases together 
with expression in connective tissue and in the walls 
of blood vessels and was quite prominent. On the 
basis of our results we can speculate that exactly epi-
theliocytes of mentioned patients demonstrate im-
mature phenotype, what is good signal for successful 
tissue remodelling after surgical operations.  From 
other hand, in general cleft lip affected epithelium 
with slight, but signifi cantly pronounced expression 
shows better transformation possibilities.
In the development of clefts, especially cleft 
palate, very important is also suffi cient proliferation 
of mesenchymal cells and synthesis of extracellular 
matrix components. Thus we can hypothese that this 
is weak and insuffi cient palate connective tissue 
stimulating process because TGFBR3 is required 
to allow (by increasing the affi nity) the binding of 
TGFBR2 to the various TGFβ isoforms (12).
A recent investigations show that TGFBR3 has 
an essential role in multiple human cancers. Thus 
scientist from China report, that the loss of TGFBR3 
expression in human oral epithelium and stroma is 
common event in oral squamous cell carcinoma. 
Using immunohistochemistry and semiquantita-
tive counting method they demonstrate moderate 
to intense expression in oral normal squamous 
epithelium (26). Mentioned fi ndings confi rm our 
results about week expression of TGFBR3 in cleft 
disordered tissue.
BMP – mediated mesenchymal proliferation is 
a key event in palatogenesis (17, 27). Suzuki with 
colleges analyze oral and maxillofacial area of hu-
man embryo immunohistochemically and conclude 
that similar in mouse and rat embryos BMP 2/4 is 
mainly localized in jaw bone, nasal epithelium, 
striated and smooth muscle (28). Another scientists 
report that immunostaining of BMP 2/4 is weak and 
not consistent in normal oral mucosa, but increase in 
the cases of oral carcinoma (29). Our results dem-
onstrated statistically signifi cant difference between 
relative amount of BMP 2/4 containing structures 
in cleft palate and cleft lip disordered tissue at all 
as well as separately in epithelium and connective 
tissue. We suppose that cleft palate affected tissue 
demonstrate more pronounced compensatory ability 
and epithelial cells facilitate cells of mesenchymal 
origin. It is very important that BMP 2/4 also have 
the ability to induce mesenchymal cells triggering 
their differentiation into osteoblasts (30).
Expression of bFGF in cleft disordered tissue 
in general was weak. It is known that expression 
of basic FGF in fi broblasts and endothelial cells 
increases in oral submucous fi brosis (31). Also dur-
ing wound healing in skin the basal keratinocytes 
and basal cells of hair follicle notably express bFGF 
(32). Moreover, oral wounds heal signifi cantly faster 
than skin and the number of bFGF positive cells in 
oral mucosa increase also faster than in skin (33). 
All mentioned results indicate signifi cant role of 
mentioned growth factor in tissue remodeling during 
physiological and patological processes, especially 
in the oral mucosa. Cleft lip affected showed a little 
pronounced relative abundance of immunoreactive 
epithelial cells while tissue from cleft palate showed 
little pronounced relative abundance of positive con-
nective tissue cells and exactly this difference was 
evaluated as statistically signifi cant. Accordingly 
cleft affected tissue, especially cleft lip disordered 
tissue show defi ciency of bFGF, however connective 
tissue from cleft palate demonstrate more possibities 
of remodeling.
Cleft lip affected tissue demonstrated more 
statistically signifi cantly prominent expression of 
FGFR1 in general as well as separately in epithe-
lium. FGFR1 is the most important receptor in the 
FGF/FGFR system, it has the highest affi nity for 
bFGF and it is widely distributed in the human body 
(34). Basic FGF/FGFR binding induces a broad 
spectrum of activities into the cells (35). Thus we 
can speculate that cleft tissue through expression 
of FGFR1 demonstrate conditioned readiness for 
remodelation, what is impossible because of slight 
expression of bFGF, except connective tissue from 
cleft palate. In general connective tissue from cleft 
palate affected tissue showed more equivalent 
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expression of mentioned growth factors and its 
receptors.
CONCLUSIONS
The marked and statistically signifi cant expres-
sion of BMP 2/4 in cleft palate disordered soft tis-
sue probably is delayed, but still proliferation and 
differentiation as well as tissue, especially, bone 
remodeling contributing signal, caused by insuf-
fi cient palate hard tissue defi ciency.
Cleft palate affected tissue show more prominent 
expression of TGFβ, still the weak regional expression 
of TGFβ type III receptors prove the disordered tissue 
growth and changed TGFβ signalling pathway in post-
natal pathogenesis what can lead to formation of defec-
tive mucosa after surgical closure of malformation.
Expression of FGFR1 is most characteristic in 
cleft lip disordered tissue, however bFGF/FGFR1 
system seems plays slight functional role only in 
cleft palate affected connective tissue what is prob-
ably insuffi cient in the case of palate defect. 
In general, expression of TGFβ, BMP 2/4 and 
FGFR1 is signifi cantly different, giving evidence 
to the involvement of this mentioned factors in the 
cleft severity morphopathogenesis.
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